Skip to main content

Ocriplasmin Ophthalmic Dosage

Applies to the following strengths: 0.5 mg/0.2 mL; 0.375 mg/0.3 mL

Usual Adult Dose for Vitreomacular Adhesion

0.125 mg (0.1 mL of the diluted solution) via intravitreal injection to the affected eye ONCE as a single dose

Comments:


Use: Treatment of symptomatic vitreomacular adhesion

Renal Dose Adjustments

No adjustment recommended.

Liver Dose Adjustments

No adjustment recommended.

Precautions

CONTRAINDICATIONS: None.

This drug is not recommended for use in children.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:


Storage requirements:

Reconstitution/preparation techniques:

General:

Monitoring:

Patient advice:

More about ocriplasmin ophthalmic

Patient resources

Other brands

Jetrea

Professional resources

Other brands

Jetrea

Related treatment guides

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.